Mpox cases nearly double what they were at the same time last year, CDC says

Cases of Mpox in the United States are experiencing a significant increase, nearly doubling compared to the same period last year, according to recent data from the CDC.

As of mid-March, there have been an estimated 511 cases nationwide year-to-date, in contrast to 287 cases during the corresponding period last year. New York City, in particular, has seen a notable surge, with over 100 cases reported this year compared to just 30 cases last year.

Mpox, formerly known as monkeypox, is a disease characterized by symptoms similar to smallpox but generally milder and rarely fatal, as stated by the CDC.

While traditionally confined to central and west Africa, cases of Mpox began emerging in the U.S. in May 2022. Since then, the CDC has reported over 32,000 cases and 58 deaths in the country. The outbreak prompted the Biden administration to declare a public health emergency in 2022, and vaccination campaigns, especially among high-risk groups, played a crucial role in containing the spread.

Dr. John Brownstein, chief innovation officer at Boston Children’s Hospital and an ABC News contributor, emphasized the importance of vaccination and collective action in combating Mpox. The recent increase in cases serves as a stark reminder of the ongoing threat of the virus and underscores the necessity for continued vigilance and preventive measures.

Although Mpox can spread between any two individuals, certain groups, including gay and bisexual men, face a higher risk due to the initial spread of the virus within this community. The virus, characterized by a painful rash and lesions, primarily transmits through skin-to-skin contact.

For those at high risk, the CDC recommends the Jynneos vaccine, which includes individuals who have been exposed to Mpox or identify as gay, bisexual, or men who have sex with other men, especially if they have multiple sexual partners or a history of sexually transmitted diseases. Additionally, individuals with HIV or other immune-compromising conditions are eligible for vaccination.

The vaccine, administered in two doses, can be given intradermally or between the skin’s top layers. At present, there are no guidelines for annual booster shots. Information on vaccine availability can be accessed on the CDC website.

Mpox typically spreads through close contact with an infected individual, including via intimate activities like sex or prolonged face-to-face interactions. Common symptoms include a rash on various parts of the body and flu-like symptoms such as fever, chills, fatigue, and headache.